Integrated structure- and ligand-basedin silicoapproach to predict inhibition of cytochrome P450 2D6
Author(s) -
Virginie Martiny,
Pablo Carbonell,
Florent Chevillard,
Gautier Moroy,
Arnaud Nicot,
Philippe Vayer,
Bruno O. Villoutreix,
Maria A. Miteva
Publication year - 2015
Publication title -
bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.599
H-Index - 390
eISSN - 1367-4811
pISSN - 1367-4803
DOI - 10.1093/bioinformatics/btv486
Subject(s) - in silico , cyp2d6 , computational biology , docking (animal) , cytochrome p450 , molecular dynamics , quantitative structure–activity relationship , chemistry , computer science , biological system , machine learning , computational chemistry , enzyme , biology , biochemistry , gene , medicine , nursing
Cytochrome P450 (CYP) is a superfamily of enzymes responsible for the metabolism of drugs, xenobiotics and endogenous compounds. CYP2D6 metabolizes about 30% of drugs and predicting potential CYP2D6 inhibition is important in early-stage drug discovery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom